The Sanford Guide to Antimicrobial Therapy 2018 [48 ed.] 1944272062

The 48th edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug informati

664 108 73MB

English Pages 262 [266] Year 2018

Report DMCA / Copyright

DOWNLOAD FILE

The Sanford Guide to Antimicrobial Therapy 2018 [48 ed.]
 1944272062

Table of contents :
Clinical syndromes
pathogens
bacterial
fungal
mycobacterial
parasitic
viral
Anti-infective agents
dosing
pediatric adjustments
renal adjustments
adverse affects
activity
pharmacology
interactions
Preventative therapy
What's new in 2018:

Table 1: meningitis, otitis media, diarrhea, cystitis, UTIs, endocarditis, CAP/HAP/VAP, SBP, appendicitis, pharyngitis, sinusitis, bites, oroya fever/verruga peruna, necrotizing fasciitis, septic shock, thrombophlebitis, botulism
Table 2: resistant bacteria, including GNB
Table 3: duration of therapy updated throughout
Table 4: organism coverage expanded, drugs added (new and old)
Table 5B: complete update
Table 9A: recent drugs added
Table 10A: recent drugs added, e.g., mero-vabor, delaflox, pip-tazo dosing updated, colistin dosing updated, including inhalation (10F)
Table 11: Isavuconazole indications and dosing
Table 13: giardia, leishmaniasis, microsporidiosis, malaria, trematodes, cestodes; antiparasitic drug updates (13B, 13D)
Table 14A: MERS, enterovirus, HSV aseptic meningitis, influenza
Table 14B: new HCV, CMV drugs
Table 14C: new ARV drugs
Table 14F: updated HCV treatment regimens and recommendations
Table 15A: post-splenectomy bacteremia, asplenia, sickle cell disease
Table 15B: colorectal, OB-Gyn, ophthalmic and general comments
Table 16: added peds dosing for additional antibacterials, ARVs, antivirals
Table 17: renal adjustments for ceftaz-avi, mero-vabor, delaflox
Table 17C: updated obesity dose adjustments
Table 17D: NEW list of antibacterials with no need to adjust dose for obesity
Table 19: comprehensive update to treatment of CAPD peritonitis
Table 22: added recent drugs

Polecaj historie